Gram-negative bacteria: Latest News, Top Stories & Analysis

MALVERN, PA — Venatorx Pharmaceuticals this week announced a comprehensive update about cefepime-taniborbactam, the Company’s intravenous beta-lactam / beta-lactamase inhibitor (BL/BLI) combination antibiotic that is being developed for the treatment …

Multistate Salmonella Outbreak Continues to Grow; Now Linked to Red Onions

National

FDA Releases Investigation Report Following 2020 Salmonella Outbreak Linked to Red Onions

May 15, 2021May 15, 2021 - by MyChesCo

WASHINGTON, D.C. — The following quote is attributed to Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response:

Infectious Diseases

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections with Limited Treatment Options

May 4, 2020May 4, 2020 - by MyChesCo

MALVERN, PA — Venatorx Pharmaceuticals and the Global Antibiotic Research and Development Partnership (GARDP) recently announced a collaboration to accelerate the development of, and access to, cefepime-taniborbactam (formerly cefepime/VNRX-5133).